Trends in deaths from respiratory illness in children in England and Wales from 1968 to 2000

Ponickar, J. R.; Dodd, S. R.; Smyth, R. L.; Couriel, J. M.
December 2005
Thorax;Dec2005, Vol. 60 Issue 12, p1035
Academic Journal
Background: Childhood mortality has decreased markedly over the last three decades. A study was undertaken to determine trends in deaths from respiratory illness in children in England and Wales. Methods: Mortality data collected by the Office for National Statistics were analysed. The data included all deaths registered from all causes in children aged between 28 days and 16 years in England and Wales from 1 January 1968 to 31 December 2000. The main outcome measures were overall and age-specific mortality rates due to all respiratory disorders and specific rates for pneumonia, asthma, cystic fibrosis (CF), and bronchiolitis. Results: In children aged 1-16 years the overall mortality rate (per 100 000 children) declined from 49.9 in 1968 to 16.3 in 2000, and rates due to respiratory illness fell from 8.6 to 1.3. The proportion of all deaths caused by respiratory illness in children aged 28 days to 16 years fell from 30.8% in 1968 to 9.9% in 2000. In post-neonatal infants (aged 28-364 days), the "all cause" mortally rate fell from 592.8 in 1968 to 176 in 2000 and the rates due to respiratory illness fell from 280 to 22.8. In 2000, pneumonia, asthma and CF together accounted for 73% of all respiratory deaths in 1-16 year aids. In this age group, mortality rates per 100 000 for pneumonia fell from 4.22 to 0.57, for asthma from 0.83 to 0.25, and for CF from 0.66 to 0.12 between 1968 and 2000. Over the same period mortality rates for pneumonia in post-neonatal infants fell from 165 to 6.78 per 100 000 and for CF from 4.88 to 0.33. Bronchiolitis mortality rates per 100 000 in post-neonatal infants fell from 21.47 in 1979 to 1.82 in 2000. Conclusions: Mortality rates due to all respiratory illnesses in children have fallen markedly in the last three decades. This decline has been more rapid than the overall decline in childhood mortality and respiratory diseases are now responsible for a smaller proportion of deaths in children. These data could provide a foundation for assessing the impact on mortality of future health initiatives such as the introduction of a universal pneumococcal vaccination programme in England and Wales.


Related Articles

  • Chapter 7: Nasal polyps. Georgy, Mary S.; Peters, Anju T. // Allergy & Asthma Proceedings;May/Jun2012 Supplement, Vol. 33, p22 

    Nasal polyps are inflammatory outgrowths of paranasal sinus mucosa caused by chronic mucosal inflammation that typically arise from the middle meatus and ethmoid region. The main symptoms of nasal polyps are perennial nasal congestion, nasal obstruction, and anosmia or hyposmia. Unlike patients...

  • Association between Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and Susceptibility for Childhood Asthma in Korea. Kyung Won Kim; Ji Hyun Lee; Min Goo Lee; Kyung Hwan Kim; Myung Hyun Sohn; Kyu-Earn Kim // Yonsei Medical Journal;11/1/2010, Vol. 51 Issue 6, p912 

    Purpose: Classic cystic fibrosis is now known part of cystic fibrosis transmembrane conductance regulator (CFTR)-related disorders. These include a wide spectrum, from multi-system disorders, such as cystic fibrosis, to mono-symptomatic conditions, such as chronic pancreatitis or congenital...

  • Respiratory diseases in pregnancy Introduction. Konx, A. J. // Thorax;Apr2001, Vol. 56 Issue 4, p324 

    The purpose of this article is to cover the important lung diseases that are likely to be encountered in pregnancy. The five articles in the series have been written by acknowledged experts in the field and provide an important source of knowledge for respiratory physicians and other specialists...

  • Impact of respiratory viral infections on cystic fibrosis. Wat, D. // Postgraduate Medical Journal;Apr2003, Vol. 79 Issue 930, p201 

    Examines the association of respiratory viral infection with pulmonary deterioration in patients with cystic fibrosis. Impact of respiratory viral infections on cystic fibrosis; Role of vaccines in decreasing the severity and complications of viral respiratory disease.

  • Respiratory Indications for Polysomnography in Children. Randel, Amber // American Family Physician;2/1/2012, Vol. 85 Issue 3, following p246 

    The article discusses the use of polysomnography (PSG) in diagnosing respiratory diseases in children. PSG testing is a reliable tool in diagnosing the presence of obstructive sleep apnea (OSA), congenital central alveolar hypoventilation, chest wall deformities, and sleep-related...

  • Diseases of the respiratory system. Hodson, Margaret E. // British Medical Journal;4/15/1978, Vol. 1 Issue 6118, p971 

    Focuses on bronchiectasis and cystic fibrosis, diseases of the respiratory system. Etiology; Symptoms and diagnosis; Causes; Treatment; Complications.

  • Infection Control in Cystic Fibrosis.  // Respiratory Care;May2009, Vol. 54 Issue 5, p654 

    A variety of medical recommendations, interviews and other clinical aids related to the articles that appeared in the May 2009 issue of "Respiratory Disease" are presented.

  • The CLCA Gene Family: Putative Therapeutic Target for Respiratory Diseases. Winpenny, John P.; Marsey, Laura L.; Sexton, Darren W. // Inflammation & Allergy - Drug Targets;Jun2009, Vol. 8 Issue 2, p146 

    The CLCA proteins were first shown to exist in bovine trachea and named as chloride channels calcium activated (CLCA) due to the calcium-dependent chloride conductance that appeared to be activated on expression of these proteins in trachea and other secretory epithelial cells. Since their...

  • Immunomodulatory Effects of Macrolide Antibiotics in Respiratory Disease: Therapeutic Implications for Asthma and Cystic Fibrosis. Sharma, Sanjiv; Jaffe, Adam; Dixon, Garth // Pediatric Drugs;2007, Vol. 9 Issue 2, p107 

    The macrolide antibiotics are a family of related 14- or 15-membered lactone ring antibiotics. There has been recent interest in the beneficial effects of these drugs as immune modulators in respiratory conditions in children. Cystic fibrosis (CF) and asthma, both of which occur in childhood,...


Read the Article


Sign out of this library

Other Topics